ArticleToxics2026
Uncovering Urinary Neonicotinoid Exposure Signatures Among Older Adults in South China: A Multicenter Biomonitoring Study.
Article in Toxics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Neonicotinoid insecticides (NEOs) are widely used neuroactive pesticides, but biomonitoring evidence among older adults remains limited. This multicenter cross-sectional study characterized urinary exposure profiles of NEOs and their metabolites among 419 older adults from South China. Ten urinary NEO biomarkers, including six parent compounds and four metabolites, were measured using high-performance liquid chromatography coupled with tandem mass spectrometry. NEOs were frequently detected in urine samples; except for thiacloprid and acetamiprid, with detection frequencies of 81.67% and 65.48%, respectively, all other compounds were detected in more than 90% of participants. Among the parent NEOs, clothianidin had the highest median concentration (1.402 μg/L), followed by dinotefuran (1.240 μg/L) and thiamethoxam (0.888 μg/L). The main metabolite was
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.